Размер и форма частиц полипиррола в водных растворах поли-( N-винилпирролидона)

Based on the IR spectroscopy data and on the analysis of rheological characteristics of polypyrrole aqueous suspension stabilized with poly-(N-vinylpyrrolidone) we conjecture that a physical lattice composed with poly-(N-vinylpyrrolidone) is formed, where the lattice points are the polypyrrole chain aggregates interlaced with poly-(N-vinylpyrrolidone) chains. It was shown that there is a hydrogen bond between the constitutional repeating units of poly-(N-vinylpyrrolidone) and polypyrrole. It was determined that the size of the particles of the disperse phase decreases with the increase of poly-(N-vinylpyrrolidone) molecular weight. It was also determined that the size of particles increases with the increase of the mass fraction of polypyrrole aqueous suspension. It was shown that the disperse phase particles are rod-like, and the increase of molecular weight of poly-(N-vinylpyrrolidone) in an aqueous solution results in additional lengthwise stretching of particles. It was also shown that the viscosity of the stabilized poly-(N-vinylpyrrolidone) aqueous suspension follows the Einstein law.На основании данных ИК-спектроскопии и анализа реологических характеристик водной суспензии полипиррола, стабилизированной поли-( N -винилпирролидоном), выдвинуто предположение об образовании физической сетки, формируемой цепями поли-( N -винилпирролидона), узлами которой являются агрегаты цепей полипиррола, переплетенные с цепями поли-( N -винилпирролидона). Установлено уменьшение размера частиц дисперсной фазы при увеличении молекулярной массы поли-( N -винилпирролидона)

The impact of transposable element activity on therapeutically relevant human stem cells

Human stem cells harbor significant potential for basic and clinical translational research as well as regenerative medicine. Currently ~ 3000 adult and ~ 30 pluripotent stem cell-based, interventional clinical trials are ongoing worldwide, and numbers are increasing continuously. Although stem cells are promising cell sources to treat a wide range of human diseases, there are also concerns regarding potential risks associated with their clinical use, including genomic instability and tumorigenesis concerns. Thus, a deeper understanding of the factors and molecular mechanisms contributing to stem cell genome stability are a prerequisite to harnessing their therapeutic potential for degenerative diseases. Chemical and physical factors are known to influence the stability of stem cell genomes, together with random mutations and Copy Number Variants (CNVs) that accumulated in cultured human stem cells. Here we review the activity of endogenous transposable elements (TEs) in human multipotent and pluripotent stem cells, and the consequences of their mobility for genomic integrity and host gene expression. We describe transcriptional and post-transcriptional mechanisms antagonizing the spread of TEs in the human genome, and highlight those that are more prevalent in multipotent and pluripotent stem cells. Notably, TEs do not only represent a source of mutations/CNVs in genomes, but are also often harnessed as tools to engineer the stem cell genome; thus, we also describe and discuss the most widely applied transposon-based tools and highlight the most relevant areas of their biomedical applications in stem cells. Taken together, this review will contribute to the assessment of the risk that endogenous TE activity and the application of genetically engineered TEs constitute for the biosafety of stem cells to be used for substitutive and regenerative cell therapiesS.R.H. and P.T.R. are funded by the Government of Spain (MINECO, RYC-2016- 21395 and SAF2015–71589-P [S.R.H.]; PEJ-2014-A-31985 and SAF2015–71589- P [P.T.R.]). GGS is supported by a grant from the Ministry of Health of the Federal Republic of Germany (FKZ2518FSB403)

Size and shape of polypyrrole particles in aqueous solutions of poly-( <i>N</i>-vinylpyrrolidone)

Based on the IR spectroscopy data and on the analysis of rheological characteristics of polypyrrole aqueous suspension stabilized with poly-(N-vinylpyrrolidone) we conjecture that a physical lattice composed with poly-(N-vinylpyrrolidone) is formed, where the lattice points are the polypyrrole chain aggregates interlaced with poly-(N-vinylpyrrolidone) chains. It was shown that there is a hydrogen bond between the constitutional repeating units of poly-(N-vinylpyrrolidone) and polypyrrole. It was determined that the size of the particles of the disperse phase decreases with the increase of poly-(N-vinylpyrrolidone) molecular weight. It was also determined that the size of particles increases with the increase of the mass fraction of polypyrrole aqueous suspension. It was shown that the disperse phase particles are rod-like, and the increase of molecular weight of poly-(N-vinylpyrrolidone) in an aqueous solution results in additional lengthwise stretching of particles. It was also shown that the viscosity of the stabilized poly-(N-vinylpyrrolidone) aqueous suspension follows the Einstein law

Detection and cloning of LINE-1 elements in CHO cells

Long interspersed elements (LINEs, L1s) are non-long terminal repeat (LTR) retrotransposons found in mammalian genomes and account up to 20% of genomic DNA. It has been shown that active L1 elements can cause mutation resulting in disease, genetic variation and polymorphisms and their inactive copies seem to be involved in recombination and rearrangement. L1–encoded products have been detected in a number of tissues including mammalian germ cell tumours, breast carcinomas and a large variety of transformed mouse and human cell lines

Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs

MicroRNAs (miRNAs) contribute to the pathogenesis of many forms of cancer, including the pediatric cancer neuroblastoma, but the underlying mechanisms leading to altered miRNA expression are often unknown. Here, a novel integrated approach for analyzing DNA methylation coupled with miRNA and mRNA expression data sets identified 67 epigenetically regulated miRNA in neuroblastoma. A large proportion (42%) of these miRNAs was associated with poor patient survival when underexpressed in tumors. Moreover, we demonstrate that this panel of epigenetically silenced miRNAs targets a large set of genes that are overexpressed in tumors from patients with poor survival in a highly redundant manner. The genes targeted by the epigenetically regulated miRNAs are enriched for a number of biological processes, including regulation of cell differentiation. Functional studies involving ectopic overexpression of several of the epigenetically silenced miRNAs had a negative impact on neuroblastoma cell viability, providing further support to the concept that inactivation of these miRNAs is important for neuroblastoma disease pathogenesis. One locus, miR-340, induced either differentiation or apoptosis in a cell context dependent manner, indicating a tumor suppressive function for this miRNA. Intriguingly, it was determined that miR-340 is upregulated by demethylation of an upstream genomic region that occurs during the process of neuroblastoma cell differentiation induced by all-trans retinoic acid (ATRA). Further biological studies of miR-340 revealed that it directly represses the SOX2 transcription factor by targeting of its 30-untranslated region, explaining the mechanism by which SOX2 is downregulated by ATRA. Although SOX2 contributes to the maintenance of stem cells in an undifferentiated state, we demonstrate that miR-340-mediated downregulation of SOX2 is not required for ATRA induced differentiation to occur. In summary, our results exemplify the dynamic nature of the miRNA epigenome and identify a remarkable network of miRNA/mRNA interactions that significantly contribute to neuroblastoma disease pathogenesis

Body weight gain/loss in mice immunized with combinations of pNP/pM1/pNS1 and challenged with 10 LD of influenza virus

<p><b>Copyright information:</b></p><p>Taken from "Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1"</p><p></p><p>Influenza and Other Respiratory Viruses 2007;1(2):71-79.</p><p>Published online Jan 2007</p><p>PMCID:PMC2040185.</p><p>© 2007 Cure Lab, Inc. Journal Compilation 2007 Blackwell Publishing Ltd</p> Mean weights (±SD) are shown for each group. *Time interval in which the difference between pNP/pM1/pNS1 and pNP/pM1/pNS1del34-immunized groups was statistically significant ( < 0.05)